Hemerion - Crunchbase Company Profile & Funding

Q: Where is Hemerion's headquarters?

Hemerion is located in Villeneuve, Picardie, France.

Q: Who invested in Hemerion?

Hemerion has 7 investors including Nord France Amorcage And Bpifrance.

Q: When was the last funding round for Hemerion?

Hemerion closed its last funding round on obfuscated from a Grant round.

Q: How much funding has Hemerion raised to date?

Hemerion has raised obfuscated.

Overview

Hemerion

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Hemerion

CB Rank

53317

Hemerion is focused on creating innovative cancer treatments.

Founded

obfuscation

Private

Grant

Villeneuve, Picardie, France

11-50

hemerion.com/

Health Care

Medical

Oncology

Funding Rounds

Grant

OBF

obfuscation

Equity Crowdfunding

OBF

obfuscation

Series A

OBF

obfuscation

Details

Legal Name

Hemerion Therapeutics SAS

Also Known As

Hemerion Therapeutics.

Operating Status

Active

Company Type

For Profit

About the Company

Hemerion is focused on creating innovative cancer treatments. The focus is on cutting-edge methods to treat glioblastoma, the most prevalent and dangerous primary brain tumour.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

Pentalafen/Heliance combination therapy

A drug-device combination therapy designed to treat glioblastoma by using a photosensitizing drug and a photonic system to selectively destroy cancer cells without harming healthy tissue.

HTX-GBM-01 clinical trial

A phase 1/2 clinical trial investigating the safety and feasibility of intraoperative photodynamic therapy with Pentalafen drug and Heliance Solution Device for patients with Grade IV glioblastoma.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Hemerion	2	obfuscated obfuscation	European Commission	Grant
obfuscated obfuscation	Grant - Hemerion	2	obfuscated obfuscation	European Commission	Grant
obfuscated obfuscation	Grant - Hemerion	2	obfuscated obfuscation	European Commission	Grant
obfuscated obfuscation	Grant - Hemerion	2	obfuscated obfuscation	European Commission	Grant
obfuscated obfuscation	Grant - Hemerion	2	obfuscated obfuscation	European Commission	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Hemerion	2	obfuscated obfuscation	European Commission	Grant
obfuscated obfuscation	Grant - Hemerion	2	obfuscated obfuscation	European Commission	Grant
obfuscated obfuscation	Grant - Hemerion	2	obfuscated obfuscation	European Commission	Grant
obfuscated obfuscation	Grant - Hemerion	2	obfuscated obfuscation	European Commission	Grant
obfuscated obfuscation	Grant - Hemerion	2	obfuscated obfuscation	European Commission	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Nord France Amorcage	—	Series A - Hemerion	—
Nord France Amorcage	—	Series A - Hemerion	—
Nord France Amorcage	—	Series A - Hemerion	—
Nord France Amorcage	—	Series A - Hemerion	—
Nord France Amorcage	—	Series A - Hemerion	—